Sofinnova Investments as of Dec. 31, 2019
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 59 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ascendis Pharma A S (ASND) | 11.1 | $154M | 1.1M | 139.12 | |
Nextcure (NXTC) | 10.8 | $151M | 2.7M | 56.33 | |
Karuna Therapeutics Ord | 10.2 | $142M | 1.9M | 75.34 | |
Amarin Corporation (AMRN) | 8.1 | $112M | 5.2M | 21.44 | |
Natera (NTRA) | 7.5 | $105M | 3.1M | 33.69 | |
Principia Biopharma | 5.6 | $78M | 1.4M | 54.78 | |
Y Mabs Therapeutics (YMAB) | 4.9 | $69M | 2.2M | 31.25 | |
Galera Therapeutics (GRTX) | 2.9 | $41M | 3.1M | 13.16 | |
BioMarin Pharmaceutical (BMRN) | 2.7 | $37M | 442k | 84.55 | |
Coherus Biosciences (CHRS) | 2.5 | $35M | 1.9M | 18.01 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.2 | $31M | 139k | 218.95 | |
Merus N V (MRUS) | 2.0 | $28M | 2.0M | 14.08 | |
Ptc Therapeutics I (PTCT) | 1.8 | $25M | 517k | 48.03 | |
Merck & Co (MRK) | 1.6 | $22M | 241k | 90.94 | |
Regeneron Pharmaceuticals (REGN) | 1.4 | $19M | 50k | 375.46 | |
Biogen Idec (BIIB) | 1.4 | $19M | 64k | 296.71 | |
Obseva Sa | 1.3 | $18M | 4.7M | 3.82 | |
United Therapeutics Corporation (UTHR) | 1.2 | $17M | 189k | 88.09 | |
Chemocentryx | 1.1 | $15M | 377k | 39.55 | |
Nucana Biomed ordinary shares | 1.1 | $15M | 2.4M | 6.10 | |
Myokardia | 1.0 | $14M | 196k | 72.88 | |
Mirati Therapeutics | 1.0 | $14M | 108k | 128.85 | |
Nucana Plc american depositary shares (NCNA) | 1.0 | $14M | 2.3M | 6.10 | |
Macrogenics (MGNX) | 0.9 | $13M | 1.2M | 10.88 | |
Fate Therapeutics (FATE) | 0.9 | $12M | 635k | 19.57 | |
ALNYLAM PHARMACEUTICALS INC. Common Stock cmn | 0.8 | $12M | 100k | 115.15 | |
Sarepta Therapeutics (SRPT) | 0.8 | $11M | 88k | 129.04 | |
Kadmon Hldgs | 0.8 | $11M | 2.4M | 4.53 | |
Kiniksa Pharmaceuticals (KNSA) | 0.7 | $10M | 923k | 11.06 | |
Medicines Company cmn | 0.7 | $9.3M | 110k | 84.94 | |
Tg Therapeutics (TGTX) | 0.7 | $9.0M | 811k | 11.10 | |
Calithera Biosciences | 0.6 | $8.3M | 1.5M | 5.71 | |
Dermira | 0.6 | $8.3M | 546k | 15.16 | |
ALEXION PHARMACEUTICALS INC CMN Stock cmn | 0.6 | $8.1M | 75k | 108.17 | |
Chiasma | 0.6 | $8.1M | 1.6M | 4.96 | |
ArQule | 0.6 | $7.7M | 388k | 19.96 | |
Acceleron Pharma | 0.6 | $7.8M | 147k | 53.01 | |
Iterum Therapeutics | 0.6 | $7.8M | 1.7M | 4.50 | |
BioCryst Pharmaceuticals (BCRX) | 0.5 | $7.4M | 2.2M | 3.45 | |
Otonomy | 0.4 | $5.8M | 1.5M | 3.83 | |
Entasis Therapeutics Holdings Ord | 0.4 | $5.9M | 1.2M | 4.97 | |
Seattle Genetics | 0.4 | $5.7M | 50k | 114.23 | |
Forty Seven | 0.4 | $5.5M | 139k | 39.37 | |
Zymeworks | 0.3 | $4.9M | 108k | 45.45 | |
Amicus Therapeutics (FOLD) | 0.3 | $4.6M | 475k | 9.74 | |
Xbiotech (XBIT) | 0.3 | $4.5M | 241k | 18.66 | |
Foamix Pharmaceuticals | 0.3 | $3.9M | 1.2M | 3.33 | |
Orchard Therapeutics Plc ads | 0.3 | $3.9M | 283k | 13.75 | |
Applied Therapeutics (APLT) | 0.3 | $3.7M | 135k | 27.27 | |
Aclaris Therapeutics (ACRS) | 0.3 | $3.6M | 1.9M | 1.89 | |
Dicerna Pharmaceuticals | 0.2 | $3.5M | 160k | 22.02 | |
Kala Pharmaceuticals | 0.2 | $2.5M | 665k | 3.69 | |
Synlogic | 0.1 | $1.5M | 575k | 2.58 | |
Apellis Pharmaceuticals (APLS) | 0.1 | $1.5M | 50k | 30.62 | |
Homology Medicines | 0.1 | $1.3M | 64k | 20.68 | |
Halozyme Therapeutics (HALO) | 0.1 | $1.3M | 73k | 17.74 | |
Heron Therapeutics (HRTX) | 0.1 | $1.2M | 51k | 23.50 | |
Rhythm Pharmaceuticals (RYTM) | 0.0 | $489k | 21k | 22.95 | |
Pds Biotechnology Ord (PDSB) | 0.0 | $378k | 143k | 2.65 |